UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Sep

    30

    Leaving a Legacy: Alicia Clark Inspires this Hispanic Heritage Month

    This Hispanic Heritage Month, we are showcasing the story of Alicia Clark, District Sales Lead, Rheumatology, as it is an inspiration to those around her both inside and outside UCB.

    Sep

    29

    New Bimekizumab Two-Year Data in Moderate to Severe Plaque Psoriasis Presented at the 30th European Academy of Dermatology and Venereology Congress

    Sep

    27

    The Art of Being Data-Enabled: UCB’s Approach to Delivering Innovative Patient Solutions

    Sep

    21

    Connecting Data Insights to Patient Impacts: Imagining the Future of UCB’s Digital Business Transformation (DBT)

    Kim Moran, UCB’s U.S. Head of Insights to Impact, is dedicated to UCB’s overall mission of creating value for people living with severe diseases. With an extensive knowledge of data and science, gained during her 14 years at UCB, Kim has put her ability to glean insights from available data to develop solutions that seek to improve the lives of people living with severe diseases.

    Sep

    07

    Our R&D Response to COVID-19: A Patients’ First Approach

    UCB’s robust global R&D response during COVID-19 focused on our patients, employees, and our communities. Read more on our overall approach from UCB's Chief Medical Officer, Iris Loew-Friedrich.  

    Sep

    01

    UCB’s Commitment to Students Living with Epilepsy

    Each year, UCB has the honor of awarding our UCB Family Epilepsy Scholarship to deserving individuals living with epilepsy, their family members, and caregivers to help them fulfill their dreams. We realize that to truly make an impact on patients’ lives, we must go beyond developing and delivering medicines, and we are committed to helping patients and their families receive the financial support they need to live their best lives possible.